Mr. Amron has served as one of our directors since January 2019. Mr. Amron is a partner and the general counsel at Wexford Capital where he is responsible for all internal legal and securities compliance matters. He joined the firm in 1994 and has been active in various private equity matters, particularly in the bankruptcy and restructuring areas, and has served on the boards and creditors’ committees of a number of public and private companies in which Wexford has held investments. Mr. Amron has served on the board of directors of Nephros, Inc. (OTCQB Marketplace: NEPH), a commercial stage medical device and commercial products company, since September 2007. Mr. Amron also served on the board of directors of the general partner of Rhino Resource Partners LP (NYSE: RNO) from January 2010 until March 2016.
Prior to joining Wexford Mr. Amron was an Associate at Schulte Roth & Zabel LLP, from 1991-1994, specializing in corporate and bankruptcy law. From 1984-1991, Mr. Amron was an Associate at Debevoise & Plimpton LLP specializing in corporate litigation and bankruptcy law.
Mr. Amron holds a JD from Harvard University, a BA in political theory from Colgate University and is a member of the New York Bar.